Key result
US mortality for coexisting HF and COPD rises ~3% annually from 2012 to 2020.
Why the study?
Heart failure and COPD are leading causes of morbidity and mortality in older adults whose coexistence complicates clinical management, prompting quantification of mortality trends and disparities.
Observational (n=1,054,847)
Effect estimate: APC 2.80 (95% CI 2.16 to 3.44)
Absolute Event Rate: 21.83% vs 17.3%
p-value: p=<0.001
Mortality from coexisting heart failure and COPD in the US has significantly increased since 2012, with persistent disparities across sex, race, and rural-urban status, highlighting the need for targeted public health interventions.
Disparities in HF-COPD mortality merit investigation; hypothesis-generating and should not yet alter practice.
Background Heart failure (HF) and Chronic Obstructive Pulmonary Disease (COPD) are leading causes of morbidity and mortality in older adults. Their coexistence poses major clinical challenges and complicates management. This study quantified and analyzed mortality trends highlighting disparities by sex, race/ethnicity, age, region, state, and urban-rural status. Methods The CDC WONDER multiple-cause mortality database was used (1999–2020), including deaths in which both HF and COPD were recorded on death certificates. Age-adjusted mortality rates (AAMRs) per 100,000, with 95% confidence intervals (CIs), were calculated across demographic, geographic, and temporal variables using ICD-10 codes. Joinpoint regression identified statistically significant ( p < 0.05) trend changes and annual percent changes (APCs). Results A total o f 1,054,847 deaths occurred in adults ≥ 15 years with both HF and COPD. In males, AAMR declined from 24.01 in 1999 to 21.22 in 2012, followed by an increase to 26.23 in 2020; in females, from 13.91 in 1999 to 14.68 in 2012 and to 18.59 in 2020. White individuals had the highest racial AAMR (19.18). The Midwest reported the highest regional AAMR (20.75), while West Virginia ranked highest among states (32.40). Noncore and micropolitan areas showed higher AAMRs compared with metropolitan areas. Conclusions Mortality associated with the coexistence of heart failure and chronic obstructive pulmonary disease in the United States has increased substantially over the past decade Persistent disparities were observed across sex, race/ethnicity, geography, and urban-rural status. These findings underscore the need for targeted public health strategies to reduce mortality and narrow disparities in high risk groups.
No takes yet. Share an insight, caveat, or question.
gul et al. (2026) conducted an observational in Coexistence of Heart Failure and Chronic Obstructive Pulmonary Disease (n=1,054,847). Temporal trends (1999-2020) was evaluated on Age-adjusted mortality rate (AAMR) per 100,000 (APC 2.80, 95% CI 2.16 to 3.44, p=<0.001). Age-adjusted mortality rates for coexisting heart failure and COPD in the United States increased significantly from 2012 to 2020 with an annual percent change of 2.80%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: